Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 1996 Nov;178(21):6305–6309. doi: 10.1128/jb.178.21.6305-6309.1996

A vancomycin-inducible lacZ reporter system in Bacillus subtilis: induction by antibiotics that inhibit cell wall synthesis and by lysozyme.

A T Ulijasz 1, A Grenader 1, B Weisblum 1
PMCID: PMC178505  PMID: 8892834

Abstract

We have constructed a Bacillus subtilis strain in which expression of a vanH::lacZ gene fusion is regulated by VanR and VanS of Enterococcus faecium. This construct allows a nonpathogenic bacterial strain to be used as a model system for studying regulation of vancomycin resistance. Antibiotics and enzymes that affect cell wall biosynthesis and stability were tested for the ability to induce lacZ expression. As a result, fosfomycin and D-cycloserine were added to the group of peptidoglycan synthesis inhibitors shown to induce expression from the vanH promoter. Induction by cell wall hydrolytic enzymes, as well as by antibiotics whose actions may lead to the accumulation of chemically different peptidoglycan precursors, raises the possibility that models that postulate induction by peptidoglycan [correction of peptidodoglycan] precursors are wrong.

Full Text

The Full Text of this article is available as a PDF (265.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen N. E., Hobbs J. N., Jr Induction of vancomycin resistance in Enterococcus faecium by non-glycopeptide antibiotics. FEMS Microbiol Lett. 1995 Oct 1;132(1-2):107–114. doi: 10.1111/j.1574-6968.1995.tb07819.x. [DOI] [PubMed] [Google Scholar]
  2. Arthur M., Depardieu F., Reynolds P., Courvalin P. Quantitative analysis of the metabolism of soluble cytoplasmic peptidoglycan precursors of glycopeptide-resistant enterococci. Mol Microbiol. 1996 Jul;21(1):33–44. doi: 10.1046/j.1365-2958.1996.00617.x. [DOI] [PubMed] [Google Scholar]
  3. Arthur M., Molinas C., Courvalin P. The VanS-VanR two-component regulatory system controls synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J Bacteriol. 1992 Apr;174(8):2582–2591. doi: 10.1128/jb.174.8.2582-2591.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Banerjee S. K., Kregar I., Turk V., Rupley J. A. Lysozyme-catalyzed reaction of the N-acetylglucosamine hexasaccharide. Dependence of rate on pH. J Biol Chem. 1973 Jul 10;248(13):4786–4792. [PubMed] [Google Scholar]
  5. Brisson-Noël A., Dutka-Malen S., Molinas C., Leclercq R., Courvalin P. Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147. Antimicrob Agents Chemother. 1990 May;34(5):924–927. doi: 10.1128/aac.34.5.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bugg T. D., Walsh C. T. Intracellular steps of bacterial cell wall peptidoglycan biosynthesis: enzymology, antibiotics, and antibiotic resistance. Nat Prod Rep. 1992 Jun;9(3):199–215. doi: 10.1039/np9920900199. [DOI] [PubMed] [Google Scholar]
  7. Dahl M. K., Meinhof C. G. A series of integrative plasmids for Bacillus subtilis containing unique cloning sites in all three open reading frames for translational lacZ fusions. Gene. 1994 Jul 22;145(1):151–152. doi: 10.1016/0378-1119(94)90341-7. [DOI] [PubMed] [Google Scholar]
  8. Dutka-Malen S., Molinas C., Arthur M., Courvalin P. The VANA glycopeptide resistance protein is related to D-alanyl-D-alanine ligase cell wall biosynthesis enzymes. Mol Gen Genet. 1990 Dec;224(3):364–372. doi: 10.1007/BF00262430. [DOI] [PubMed] [Google Scholar]
  9. Fisher S. L., Jiang W., Wanner B. L., Walsh C. T. Cross-talk between the histidine protein kinase VanS and the response regulator PhoB. Characterization and identification of a VanS domain that inhibits activation of PhoB. J Biol Chem. 1995 Sep 29;270(39):23143–23149. doi: 10.1074/jbc.270.39.23143. [DOI] [PubMed] [Google Scholar]
  10. Gold H. S., Unal S., Cercenado E., Thauvin-Eliopoulos C., Eliopoulos G. M., Wennersten C. B., Moellering R. C., Jr A gene conferring resistance to vancomycin but not teicoplanin in isolates of Enterococcus faecalis and Enterococcus faecium demonstrates homology with vanB, vanA, and vanC genes of enterococci. Antimicrob Agents Chemother. 1993 Aug;37(8):1604–1609. doi: 10.1128/aac.37.8.1604. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Handwerger S., Kolokathis A. Induction of vancomycin resistance in Enterococcus faecium by inhibition of transglycosylation. FEMS Microbiol Lett. 1990 Jul;58(2):167–170. doi: 10.1111/j.1574-6968.1990.tb13972.x. [DOI] [PubMed] [Google Scholar]
  12. Hayden M. K., Trenholme G. M., Schultz J. E., Sahm D. F. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J Infect Dis. 1993 May;167(5):1224–1227. doi: 10.1093/infdis/167.5.1224. [DOI] [PubMed] [Google Scholar]
  13. Henkin T. M., Chambliss G. H. Genetic mapping of a mutation causing an alteration in Bacillus subtilis ribosomal protein S4. Mol Gen Genet. 1984;193(2):364–369. doi: 10.1007/BF00330694. [DOI] [PubMed] [Google Scholar]
  14. Holman T. R., Wu Z., Wanner B. L., Walsh C. T. Identification of the DNA-binding site for the phosphorylated VanR protein required for vancomycin resistance in Enterococcus faecium. Biochemistry. 1994 Apr 19;33(15):4625–4631. doi: 10.1021/bi00181a024. [DOI] [PubMed] [Google Scholar]
  15. Kline S. A., de la Harpe J., Blackburn P. A colorimetric microtiter plate assay for lysostaphin using a hexaglycine substrate. Anal Biochem. 1994 Mar;217(2):329–331. doi: 10.1006/abio.1994.1127. [DOI] [PubMed] [Google Scholar]
  16. Lai M. H., Kirsch D. R. Induction signals for vancomycin resistance encoded by the vanA gene cluster in Enterococcus faecium. Antimicrob Agents Chemother. 1996 Jul;40(7):1645–1648. doi: 10.1128/aac.40.7.1645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Messing J. New M13 vectors for cloning. Methods Enzymol. 1983;101:20–78. doi: 10.1016/0076-6879(83)01005-8. [DOI] [PubMed] [Google Scholar]
  18. Mullis K. B., Faloona F. A. Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol. 1987;155:335–350. doi: 10.1016/0076-6879(87)55023-6. [DOI] [PubMed] [Google Scholar]
  19. Murray B. E. New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. J Infect Dis. 1991 Jun;163(6):1184–1194. [PubMed] [Google Scholar]
  20. Robinson J. M., Hardman J. K., Sloan G. L. Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus. J Bacteriol. 1979 Mar;137(3):1158–1164. doi: 10.1128/jb.137.3.1158-1164.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rosato A., Pierre J., Billot-Klein D., Buu-Hoi A., Gutmann L. Inducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium. Antimicrob Agents Chemother. 1995 Apr;39(4):830–833. doi: 10.1128/aac.39.4.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. SCHINDLER C. A., SCHUHARDT V. T. LYSOSTAPHIN: A NEW BACTERIOLYTIC AGENT FOR THE STAPHYLOCOCCUS. Proc Natl Acad Sci U S A. 1964 Mar;51:414–421. doi: 10.1073/pnas.51.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Sahm D. F., Free L., Handwerger S. Inducible and constitutive expression of vanC-1-encoded resistance to vancomycin in Enterococcus gallinarum. Antimicrob Agents Chemother. 1995 Jul;39(7):1480–1484. doi: 10.1128/aac.39.7.1480. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Shlaes D. M., Al-Obeid S., Shlaes J. H., Boisivon A., Williamson R. Inducible, transferable resistance to vancomycin in Enterococcus faecium, D399. J Antimicrob Chemother. 1989 Apr;23(4):503–508. doi: 10.1093/jac/23.4.503. [DOI] [PubMed] [Google Scholar]
  25. Spera R. V., Jr, Farber B. F. Multidrug-resistant Enterococcus faecium. An untreatable nosocomial pathogen. Drugs. 1994 Nov;48(5):678–688. doi: 10.2165/00003495-199448050-00003. [DOI] [PubMed] [Google Scholar]
  26. Strominger J. L. Penicillin-sensitive enzymatic reactions in bacterial cell wall synthesis. Harvey Lect. 1968 1969;64:179–213. [PubMed] [Google Scholar]
  27. Swartz M. N. Hospital-acquired infections: diseases with increasingly limited therapies. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2420–2427. doi: 10.1073/pnas.91.7.2420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Wadstrom T., Vesterberg O. Studies on endo-beta-acetylglucosaminidase, staphylolytic peptidase, and N-acetylmuramyl-L-alanine amidase in lysostaphin and from Staphylococcus aureus. Acta Pathol Microbiol Scand B Microbiol Immunol. 1971;79(2):248–264. doi: 10.1111/j.1699-0463.1971.tb02152.x. [DOI] [PubMed] [Google Scholar]
  29. Wright G. D., Holman T. R., Walsh C. T. Purification and characterization of VanR and the cytosolic domain of VanS: a two-component regulatory system required for vancomycin resistance in Enterococcus faecium BM4147. Biochemistry. 1993 May 18;32(19):5057–5063. doi: 10.1021/bi00070a013. [DOI] [PubMed] [Google Scholar]
  30. Young F. E. Fractionation and partial characterization of the products of autolysis of cell walls of Bacillus subtilis. J Bacteriol. 1966 Oct;92(4):839–846. doi: 10.1128/jb.92.4.839-846.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES